Department news

Institute of Biomedical Engineering (BME) news

University Professor Peter Zandstra (IBBME) will be receiving the Scale-Up and Manufacturing of Cell-Based Therapies Award from Engineering Conferences International. (Credit: Neil Ta).

Peter Zandstra recognized for contributions to development and commercialization of stem cell-based therapies

IBBME University Professor to receive Scale-Up and Manufacturing of Cell-Based Therapies Award at Engineering Conferences International

SensOR is a company that makes it easier for surgeons to operate at a distance by providing a way to sense the amount of force being applied to their instruments. The team includes (from left to right): Justin Wee (ECE 1T3, IBBME PhD candidate), co-founder and chief technical officer; Leigh Masotti, head of business development; and Robert Brooks (MIE PhD 1T5), co-founder and chief executive officer.  (Photo: Neil Ta)

Three startups to watch from Demo Day at U of T Engineering’s Entrepreneurship Hatchery

Companies include a robotic exoskeleton for children with physical disabilities, an electronic “smart skin” that helps surgeons avoid errors and a meal replacement that promotes cognitive health

A landmark bequest from Erwin Edward Hart (CivE 4T0, centre) created the Percy Edward Hart and Erwin Edward Hart Professorships, awarded to seven U of T Engineering researchers.

Hart Professorships awarded to seven early-career faculty members

Professorships created by a landmark bequest from the estate of alumnus Erwin Edward Hart (CivE 4T0)

University Professor Michael Sefton (IBBME, ChemE), University of Toronto biomedical engineering University Professor Michael Sefton (IBBME, ChemE) has been awarded the Lifetime Achievement Award from the Tissue Engineering & Regenerative Medicine International Society. (Credit: Neil Ta)

Michael Sefton to receive Lifetime Achievement Award from the Tissue Engineering & Regenerative Medicine International Society

The award, issued by the organization’s Americas chapter, recognizes immense contributions to the fields of tissue engineering and regenerative medicine

U of T doctoral researchers Iliya Sigal (right) and Dene Ringuette are part of a team that designed a miniature microscope that could open new doors for epilepsy and seizure monitoring and treatment. (Credit: Luke Ng).

Battery-sized microscope gives new insights into brain activity during seizures

Technique could offer insights into what causes epilepsy, and lead to more effective treatments for more than 15,000 Canadians diagnosed each year

Six U of T Engineering professors have received Early Researcher Awards from the Ontario Ministry of Research, Innovation and Science.

Early Researcher Awards support U of T Engineering research on smart materials, cancer technology and more

Awards provide critical support that helps promising scientists and engineers in the first five years of their academic careers build their research teams

Vahid Raeesi (Photo: Tyler Irving)

Multi-functional, modular nanoparticles could help fight cancer

New cancer-fighting nanoparticles developed at U of T Engineering carry out multiple functions to kill cancer cells while leaving healthy ones alone. They consist of a gold nanorod core (yellow, at left) surrounded by smaller gold spheres and linked via strands of DNA containing anti-cancer drug (red). The spheres are coated with a polymer film […]

U of T researchers Sonya MacParland (right) and Kim Tsoi (IBBME PhD 1T6) are the lead authors on a four-year study that showed how the liver and spleen trapped cancer nanomedicine, preventing them from reaching their intended targets. (Photo: Peter Church)

Understanding a key roadblock behind nanoparticle cancer drug delivery

A new paper from Prof. Warren Chan and colleagues is shedding light on how the liver interacts with nanoparticles

University of Toronto professor John E. Davies (IBBME) is part of a research team that has engineered stem cells to improve antibody therapy used to treat conditions such as Crohn’s Disease and certain cancers. (Photo: Luke Ng)

Engineering stem cells to enhance antibody therapy

Canadian researchers first to demonstrate that stem cells can be used to deliver antibodies more effectively than administration of the antibodies themselves